Blog

Paul Hemings - decades across investment banking, healthcare, and boardrooms distilled into five rules he never breaks.

Nadiia Wyttenbach shares her experience of bringing lessons from Medicine & Life Sciences into the boardroom for high-performing boards.

Nadiia Wyttenbach shares why she chose to dedicate her PhD to tackling obesity and type 2 diabetes. Reason 1.  From Stigma to Understanding Nearly 17 years ago, I chose to pursue a PhD in Molecular Health focused on obesity and cardiometabolic disorder . It wasn’t the obvious path – obesity was under the radar, unlike today. Back then, obesity was treated as a willpower problem. Molecular health was underexplored - and that showed up in bad guidance (remember the era of “just

By Nadiia Wyttenbach and Paul Hemings Healthcare AI has matured. Today we see companies generating $10–300m in revenues, with multi-year contracts scaling to $40–60m, near-zero churn, and profitability within 12–18 months. Unlike consumer AI, errors in healthcare carry life- and-death consequences, so specialist, clinically grounded providers win where generalists and Big Tech consistently struggle. Based on tenders and commercial track records across Europe, the US, and MENA